Showing results (1-10 of 117) with videos related to
Sort By:
Pageof 12
Experimental Neurology|May 17, 2021
Brief history of the medical and non-medical use of amphetamine-like psychostimulantsMicaela Morelli, Eugenia TognottiNeurotoxicity Research|December 11, 2013
A critical evaluation of behavioral rodent models of motor impairment used for screening of antiparkinsonian activity: The case of adenosine A(2A) receptor antagonistsAnnalisa Pinna, Micaela MorelliHandbook of Experimental Pharmacology|September 23, 2010
Methylxanthines and drug dependence: a focus on interactions with substances of abuseMicaela Morelli, Nicola SimolaPsychopharmacology|July 18, 2002
Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonistsOmar Cauli, Micaela MorelliEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 2, 2015
Repeated amphetamine administration and long-term effects on 50-kHz ultrasonic vocalizations: possible relevance to the motivational and dopamine-stimulating properties of the drugNicola Simola, Micaela MorelliInternational Journal of Molecular Sciences|June 28, 2023
Neurobiology of Parkinson's DiseaseMicaela Morelli, Annalisa PinnaBehavioural Brain Research|June 3, 2006
Sensitization to caffeine and cross-sensitization to amphetamine: influence of individual response to caffeineNicola Simola, Omar Cauli, Micaela MorelliThe International Journal of Neuropsychopharmacology|May 21, 2015
Involvement of Glutamate NMDA Receptors in the Acute, Long-Term, and Conditioned Effects of Amphetamine on Rat 50 kHz Ultrasonic VocalizationsGiulia Costa, Micaela Morelli, Nicola SimolaBehavioural Pharmacology|November 16, 2005
Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D(1) but not D(2) receptor agonistsOmar Cauli, Annalisa Pinna, Micaela MorelliNeuropharmacology|January 7, 2023
Serotonin 5-HT1A receptors and their interactions with adenosine A2A receptors in Parkinson's disease and dyskinesiaAnnalisa Pinna, Pathik Parekh, Micaela MorelliPageof 12